Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.19 is 20% below its 2-year average of 1.49, around the middle of its 2-year range (0.00–3.20).
As of the fiscal period ended Tuesday, June 30, 2026. 33.26% below its 12-month average of 1.78.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.19.
CURRENT RATIO
1.19
CURRENT RATIO AVG TTM
1.78
CURRENT RATIO AVG 3Y
N/A
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-33.26%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-68.35%
vs the sector median at left
Market Cap
$344.04M
Current Ratio
29.52
TTM Avg
9.54
3Y Avg
9.83
5Y Avg
10.59
Market Cap
$349.70M
Current Ratio
8.26
TTM Avg
5.36
3Y Avg
5.81
5Y Avg
4.44
Market Cap
$353.88M
Current Ratio
3.76
TTM Avg
4.71
3Y Avg
6.65
5Y Avg
8.92
Market Cap
$355.43M
Current Ratio
24.16
TTM Avg
12.00
3Y Avg
8.65
5Y Avg
7.93
Market Cap
$359.53M
Current Ratio
5.85
TTM Avg
6.36
3Y Avg
5.52
5Y Avg
8.17
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Turn Therapeutics Inc. (TTRX) | $346.73M | 1.19 | 1.78 | N/A | N/A |
| Relmada Therapeutics, Inc. (RLMD)vs › | $344.04M | 29.52 | 9.54 | 9.83 | 10.59 |
| Orchestra BioMed Holdings, Inc. (OBIO)vs › | $349.70M | 8.26 | 5.36 | 5.81 | 4.44 |
| Ocugen, Inc. (OCGN)vs › | $352.67M | 0.80 | 1.96 | 2.47 | 5.28 |
| Embecta Corp. (EMBC)vs › | $353.00M | 1.68 | 2.22 | 2.19 | 2.04 |
| Enanta Pharmaceuticals, Inc. (ENTA)vs › | $353.88M | 3.76 | 4.71 | 6.65 | 8.92 |
| Viemed Healthcare, Inc. (VMD)vs › | $355.36M | 1.13 | 1.30 | 1.47 | 1.77 |
| Artiva Biotherapeutics, Inc. (ARTV)vs › | $355.43M | 24.16 | 12.00 | 8.65 | 7.93 |
| Fennec Pharmaceuticals Inc. (FENC)vs › | $359.53M | 5.85 | 6.36 | 5.52 | 8.17 |
| Opus Genetics, Inc. (IRD)vs › | $361.64M | 12.19 | 4.83 | 10.20 | 8.85 |
Current Ratio
1.19
Quick Ratio
1.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.19 |
| 2026-03-31 | 2.23 |
| 2025-12-31 | 0.87 |
| 2025-09-30 | 1.43 |
| 2025-06-30 | 3.20 |
| 2024-06-30 | 0.00 |
